Overview

Idiopathic thrombocytopenic purpura (ITP) is a disorder that can lead to easy or excessive bruising and bleeding. The bleeding results from unusually low levels of platelets — the cells that help blood clot.

Idiopathic thrombocytopenic purpura, which is also called immune thrombocytopenia, affects children and adults. Children often develop ITP after a viral infection and usually recover fully without treatment. In adults, the disorder is often long term.

If you don't have signs of bleeding and your platelet count isn't too low, you may not need any treatment. In rare cases, the number of platelets may be so low that dangerous internal bleeding occurs. Treatment options are available.

Idiopathic thrombocytopenic purpura (ITP) care at Mayo Clinic

April 23, 2016
References
  1. AskMayoExpert. Immune thrombocytopenia (ITP). Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. AskMayoExpert. Spleen disorders and splenectomy. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  3. Immune thrombocytopenia (ITP). Merck Manual Professional Version. http://www.merckmanuals.com/professional/hematology-and-oncology/thrombocytopenia-and-platelet-dysfunction/immune-thrombocytopenia-(itp). Accessed Feb. 10, 2016.
  4. Yeo CJ, et al., eds. Splenectomy for conditions other than trauma. In: Shackelford's Surgery of the Alimentary Tract. 7th ed. Philadelphia, Pa.: Elsevier Saunders; 2013.
  5. Immune thrombocytopenic? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/itp. Accessed Feb. 9, 2016.
  6. George JN, et al. Immune thrombocytopenia (ITP) in adults: Clinical manifestations and diagnosis. http://www.uptodate.com/home. Accessed Feb. 10, 2016.
  7. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Feb. 11, 2016.
  8. Neunert C, et al. The American Society of Hematology 2011 evidence-based guidelines for immune thrombocytopenia. Blood. 2011;117:4190.
  9. CBC with differential, blood. Mayo Medical Laboratories. http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/9109. Accessed Feb. 12, 2016.
  10. George JN, et al. Approach to the adult with unexplained thrombocytopenia. http://www.uptodate.com/home. Accessed Feb. 11, 2016.
  11. George JN, et al. Immune thrombocytopenia (ITP) in adults: Initial treatment and prognosis. http://www.uptodate.com/home. Accessed Feb. 10, 2016.
  12. George JN, et al. Immune thrombocytopenia (ITP) in adults: Second-line and subsequent therapies. http://www.uptodate.com/home. Accessed Feb. 10, 2016.
  13. Leandro MJ. Rituximab and other B cell targeted therapies for rheumatoid arthritis. http://www.uptodate.com/home. Accessed Feb. 16, 2016.
  14. Imuran (azathioprine). U.S. Food and Drug Administration. http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016324s037,017391s016lbl.pdf. Accessed Feb. 16, 2016.
  15. Arnold DM. Positioning new treatments in the management of immune thrombocytopenia. Pediatric Blood & Cancer. 2013;60:S19.
  16. Mesa RA (expert opinion). Mayo Clinic, Scottsdale/Phoenix, Ariz. Feb. 17, 2016.